Data / Form D filings / CellAegis Devices Inc.
CellAegis Devices Inc.: Form D filings
CellAegis Devices Inc., a biotechnology company in Toronto, Ontario, Canada, filed 15 Form D notices with the SEC between 2013 and 2017. The latest, on March 10, 2017, reports $3.1 million sold of a $3.1 million offering to 5 investors.
Find out what CellAegis Devices Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 139 MULOCK AVE., 1ST FLOOR, Toronto, Ontario, Canada, M6N 1
- Phone
- (647) 722-9601
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Ontario, Canada
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1573661
The full lists. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 10, 2017 | Amendment | $3,114,304 | $3,114,304 | $0 | 5 | Mar 1, 2017 | sec.gov |
| Mar 10, 2017 | Amendment | $3,114,304 | $3,114,304 | $0 | 5 | Mar 1, 2017 | sec.gov |
| Mar 9, 2017 | New notice | $8,650 | $8,650 | $0 | 1 | Feb 10, 2017 | sec.gov |
| Mar 9, 2017 | New notice | $385 | $385 | $0 | 1 | Sep 2, 2016 | sec.gov |
| Mar 9, 2017 | New notice | $13,615 | $13,615 | $0 | 1 | Sep 1, 2016 | sec.gov |
| Mar 9, 2017 | New notice | $617 | $617 | $0 | 1 | Aug 24, 2016 | sec.gov |
| Mar 9, 2017 | New notice | $2,500 | $2,500 | $0 | 1 | Jul 28, 2016 | sec.gov |
| Mar 9, 2017 | New notice | $311 | $311 | $0 | 1 | Aug 30, 2016 | sec.gov |
| Mar 9, 2017 | New notice | $6,386 | $6,386 | $0 | 1 | Aug 11, 2016 | sec.gov |
| Mar 9, 2017 | New notice | $6,400 | $6,400 | $0 | 1 | Jul 27, 2016 | sec.gov |
| Mar 9, 2017 | New notice | $3,114,304 | $3,114,304 | $0 | 5 | Mar 1, 2017 | sec.gov |
| May 9, 2016 | Amendment | $81,108 | $81,108 | $0 | 5 | Mar 24, 2016 | sec.gov |
| Apr 6, 2016 | New notice | $32,500 | $32,500 | $0 | 2 | Mar 24, 2016 | sec.gov |
| Jul 19, 2013 | New notice | $772,689 | $4,947 | $767,742 | 1 | Jul 10, 2013 | sec.gov |
| Apr 3, 2013 | New notice | $23,693 | $23,693 | $0 | 3 | Mar 21, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Donna Parr | Executive Officer, Director | |
| Brian Roberts | Director | |
| Chris Colecchi | Director | |
| Rocky Ganske | Executive Officer, Director | |
| Eric Knudsen | Director | |
| John Berton | Executive Officer, Director | |
| Shermaine Tilley | Director |
Every Form D from the week of Mar 6, 2017 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what CellAegis Devices Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.